Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review
Ethnic minorities are disproportionately impacted by prostate cancer (PCa) and are at risk for not receiving informed decision making (IDM). We conducted a systematic literature review on interventions to improve: (1) IDM about PCa in screening-eligible minority men, and (2) quality of life (QOL) in minority PCa survivors.
MeSH headings for PCa, ethnic minorities, and interventions were searched in MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHL, and PsycINFO.
SUBJECT ELIGIBILITY CRITERIA
We identified U.S.-based, English-language articles (1985 – 2010) on interventions to improve PCa IDM and QOL that included 50 % or more minority patients or analyses stratified by race/ethnicity.
STUDY APPRAISAL AND SYNTHESIS METHODS
Articles (n = 19) were evaluated and scored for quality using a Downs and Black (DB) system. Interventions were organized by those enhancing 1) IDM about PCa screening and 2) improving QOL and symptom among PCa survivors. Outcomes were reported by intervention type (educational seminar, printed material, telephone-based, video and web-based).
Fourteen studies evaluated interventions for enhancing IDM about PCa screening and five evaluated programs to improve outcomes for PCa survivors. Knowledge scores were statistically significantly increased in 12 of 13 screening studies that measured knowledge, with ranges of effect varying across intervention types: educational programs (13 % – 48 % increase), print (11 % – 18 %), videotape/DVD (16 %), and web-based (7 % – 20 %). In the final screening study, an intervention to improve decision-making about screening increased decisional self-efficacy by 9 %. Five cognitive-behavioral interventions improved QOL among minority men being treated for localized PCa through enhancing problem solving and coping skills.
Weak study designs, small sample sizes, selection biases, and variation in follow-up intervals across studies.
Educational programs were the most effective intervention for improving knowledge among screening-eligible minority men. Cognitive behavioral strategies improved QOL for minority men treated for localized PCa.
Systematic review registration number
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. CrossRef
- Williams H, Powell IJ. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol Biol. 2009;472:439–53. CrossRef
- Gwede CK, McDermott RJ. Prostate cancer screening decision making under controversy: implications for health promotion practice. Health Promot Pract. 2006;7(1):134–46. CrossRef
- Minardi D, Galosi AB, Recchioni A, Giammarco L, Polito M, Muzzonigro G. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients. Urol Int. 2001;67(4):272–82. CrossRef
- Eschenbach A, Ho R, Murphy G, Cunningham M, Lins N. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 1997. CA Cancer J Clin. 1997;47:261–4. CrossRef
- U.S. Preventive Services Task Force. Screening for Prostate Cancer: US Preventitive Services Task Force Recommendation Statement (DRAFT). 2011. http://www.uspreventiveservicestaskforce.org/uspstf12/prostate/draftrecprostate.htm. Accessed on April 02, 2012.
- Guide to Clinical Preventive Services. United States Preventive Services Task Force. Alexandria, VA: International Medical Publishing; 2nd ed. 1996:119–34.
- Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998;36(9):1337–48. CrossRef
- Chan E, McFall S, Byrd T, et al. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT. Patient Educ Couns. 2011;84(2):44–51. CrossRef
- Barry MJ. Screening for prostate cancer--the controversy that refuses to die. N Engl J Med. 26 2009;360(13):1351–4. CrossRef
- Chu K, Tarone R, Freeman H. Trends in prostate cancer mortality among black men and white men in the United States. Cancer. 2003;97(6).
- Demark-Wahnefried W, Schildkraut JM, Iselin CE, et al. Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer. 1998;83(2):320–30. CrossRef
- Dimah K. Prostate cancer among African American men: a review of empirical literature. J Afr Am Stud. 2003;7(1):28–46.
- Tillman LC. Culturally sensitive research approaches: an African-American perspective. Educ Res. 2002;31(9):3–12. CrossRef
- Andersen BL. Behavioral outcomes following psychological interventions for cancer patients.J Consult Clin Psychol. 2002;70(3):590–610. CrossRef
- Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS med. 2009;6(7):e1000097.
- Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377. CrossRef
- Kripalani S, Sharma J, Justice E, et al. Low-literacy interventions to promote discussion of prostate Cancer: a randomized controlled trial. Am J Prev Med. 2007;33(2):83–90. CrossRef
- Barber K, Shaw R, Folts M, et al. Differences between African American and Caucasian men participating in a community-based prostate cancer screening program. J Community Health. 1998;23(6):441–51. CrossRef
- Boehm S, Coleman-Burns P, Schlenk E, Funnell M, Parzuchowski J, Powell I. Prostate cancer in African American men: increasing knowledge and self-efficacy. J Community Health Nurs. 1995;12(3):161–9. CrossRef
- Carter VL, Tippett F, Anderson DL, Tameru B. Increasing prostate cancer screening among African American men. J Health Care for Poor Underserved. 2010;21(3A):91–106. CrossRef
- Collins M. Increasing prostate cancer awareness in African American men. Oncol Nurs Forum. 1997;24(1):91.
- Drake B, Shelton R, Gilligan T, Allen J. A church-based intervention to promote informed decision making for prostate cancer screening among African American men. J Natl Med Assoc. 2010;102(3):164–71.
- Ellison G, Weinrich S, Lou M, Hongyan X, Powell I, Baquet C. A randomized trial comparing web-based decision aids on prostate cancer knowledge for African-American men. J Natl Med Assoc. 2008;100(10):1139–45.
- Holt C, Wynn T, Litaker M, Southward P, Jeames S, Schulz E. A comparison of a spiritually based and non-spiritually based educational intervention for informed decision making for prostate cancer screening among church-attending African-American men. Urol Nurs. 2009;29(4):249.
- Powell I, Heilbrun L, Littrup P, et al. Outcome of African American men screened for prostate cancer: The Detroit Education and Early Detection Study. J Urol. 1997;158(1):146–9. CrossRef
- Stephens RL, Xu Y, Volk RJ, et al. Influence of a patient decision aid on decisional conflict related to PSA testing: A structural equation model. Health Psychol. 2008;27(6):711–21. CrossRef
- Taylor K, Davis J, Turner R, et al. Educating African American men about the prostate cancer screening dilemma: a randomized intervention. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2179. CrossRef
- Weston R, Weston P, Futterman R, et al. Effectiveness of a modified computer assisted instructional tool in the dissemination of prostate cancer information to men of African descent through black churches. J Afr Am Stud. 2007;11(2):140–56. CrossRef
- Wilkinson S, List M, Sinner M, Dai L, Chodak G. Educating African-American men about prostate cancer: impact on awareness and knowledge. Urology. 2003;61(2):308–13. CrossRef
- Husaini B, Reece M, Emerson J, Scales S, Hull P, Levine R. A church-based program on prostate cancer screening for African American men: reducing health disparities. Ethn Dis. 2008;18:179–84.
- Powell I, Gelfand D, Parzuchowski J, Heilbrun L, Franklin A. A successful recruitment process of African American men for early detection of prostate cancer. Cancer. 1995;75(S7):1880–4. CrossRef
- Penedo F, Dahn J, Molton I, et al. Cognitive behavioral stress management improves stress management skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer. 2004;100(1):192–200. CrossRef
- Penedo F, Traeger L, Dahn J, et al. Cognitive behavioral stress management intervention improves quality of life in Spanish monolingual Hispanic men treated for localized prostate cancer: results of a randomized controlled trial. Int J Behav Med. 2007;14(3):164–72. CrossRef
- Campbell L, Keefe F, Scipio C, et al. Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. Cancer. 2007;109(S2):414–24. CrossRef
- Antoni MH. Stress management effects on psychological, endocrinological, and immune functioning in men with HIV infection: empirical support for a psychoneuroimmunological model. Stress: Int J Biol Stress. 2003;6(3):173–88. CrossRef
- Mishel M, Belyea M, Germino B, et al. Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects. Cancer. 2002;94(6):1854–66. CrossRef
- Mishel M, Germino B, Lin L, et al. Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns. 2009;77(3):349–59. CrossRef
- Partin MR, Nelson D, Radosevich D, et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med. 2004;19(8):835–42. CrossRef
- Volk RJ, Hawley ST, Kneuper S, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am j prev med. 2007;33(5):428–34. e411. CrossRef
- Evans R, Joseph-Williams N, Edwards A, et al. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial. J Med Internet Res. 2010;12(3).
- Handley MR, Stuart ME. The use of prostate specific antigen for prostate cancer screening: a managed care perspective. J Urol. 1994;152(5 Pt 2):1689.
- Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psycho-Oncol. 2002;11(4):307–26. CrossRef
- Penedo FJ, Dahn JR, Shen BJ, Schneiderman N, Antoni MH. Ethnicity and determinants of quality of life after prostate cancer treatment. Urology. 2006;67(5):1022–7. CrossRef
- Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CAPSURE. Urology. 1999;54(3):503–8. CrossRef
- Melmed GY, Kwan L, Reid K, Litwin MS. Quality of life at the end of life: trends in patients with metastatic prostate cancer. Urology. 2002;59(1):103–9. CrossRef
- Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 2003;22(5):443. CrossRef
- Kon AA. The shared decision-making continuum. JAMA: J Am Med Assoc. 2010;304(8):903–4. CrossRef
- Sajid S, Mohile SG, Szmulewitz R, Posadas E, Dale W. Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum. Semin Oncol. 2011;38(2):309–25. CrossRef
- Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Journal of General Internal Medicine
Volume 27, Issue 8 , pp 1068-1078
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- prostate cancer
- informed decision making
- African American
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, Section of Geriatrics & Palliative Medicine, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC6098, Chicago, IL, 60637, USA
- 2. Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, USA